We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

AZN Astrazeneca Plc

-124.00 (-1.12%)
Last Updated: 12:48:00
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -124.00 -1.12% 10,978.00 10,974.00 10,978.00 11,098.00 10,878.00 11,060.00 1,459,543 12:48:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceutical Preparations - - 212.2 51.8 170,049.22

AstraZeneca Says Cancer Drug Enhertu Showed Positive Results

06/03/2023 7:41am

Dow Jones News

Astrazeneca (LSE:AZN)
Historical Stock Chart

From Oct 2022 to Oct 2023

Click Here for more Astrazeneca Charts.

By Elena Vardon


AstraZeneca PLC on Monday said its cancer drug Enhertu has shown clinically meaningful and durable responses across multiple HER2-expressing advanced solid tumors in its DESTINY-PanTumor02 Phase II trial.

The Anglo-Swedish pharma major said Enhertu--trastuzumab deruxtecan, which it is jointly developing and commercializing with Daiichi Sankyo--had met prespecified criteria for objective response rate and duration of response.

"Enhertu has already demonstrated its potential to improve outcomes for patients with HER2-targetable breast, gastric and lung cancers, and these positive initial results in other tumor settings with significant unmet need are very encouraging," said Chief Medical Officer and Oncology Chief Development Officer Cristian Massacesi.


Write to Elena Vardon at elena.vardon@wsj.com


(END) Dow Jones Newswires

March 06, 2023 02:26 ET (07:26 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: gb D: 20231002 12:03:22